Association between idiopathic pulmonary fibrosis and coronary artery disease: a case-control study and cohort

Won-Young Kim1, Yejin Mok, Go Woon Kim

  • 1Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. steve8126@hanmail.net.

Insights

Idiopathic pulmonary fibrosis (IPF) patients have a higher risk of coronary artery disease (CAD). This study found IPF is an independent risk factor for CAD, even after accounting for other common risk factors.

Area of Science:

  • Cardiology
  • Pulmonology
  • Epidemiology

Background:

  • Idiopathic pulmonary fibrosis (IPF) is associated with an increased risk of coronary artery disease (CAD).
  • Limited data exists on specific CAD risk factors in IPF patients.
  • This study aimed to investigate CAD prevalence and risk factors in IPF.

Purpose of the Study:

  • To determine the prevalence of coronary artery disease (CAD) in patients with idiopathic pulmonary fibrosis (IPF).
  • To identify and analyze risk factors associated with CAD in the IPF population.
  • To compare CAD incidence in IPF patients versus a control group.

Main Methods:

  • A cohort study comparing 460 IPF patients with 1,925 matched controls.
  • Data collected included cardiovascular risk factors and CAD prevalence.
  • Follow-up analysis assessed the incidence of newly diagnosed CAD in both groups.

Main Results:

  • The prevalence of CAD was 7% in IPF patients, double that of controls (3%).
  • IPF patients had higher rates of diabetes, while controls had more hypertension and hypercholesterolemia.
  • Multivariate analysis identified age, hypertension, hypercholesterolemia, and IPF as significant CAD risk factors. Newly diagnosed CAD incidence was higher in IPF patients during follow-up (6.8% vs. 2.8%).

Conclusions:

  • Idiopathic pulmonary fibrosis (IPF) is an independent risk factor for coronary artery disease (CAD).
  • This association remains significant after adjusting for age, hypertension, diabetes, and hypercholesterolemia.
  • Findings highlight the importance of considering cardiovascular health in IPF management.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
901
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K